通过SLC1A5-依赖的谷氨胺运输阻塞向肺纤维化
Malay Choudhury1, Kyle J Schaefbauer1, Theodore J Kottom1
1Thoracic Disease Research Unit, Division of Pulmonary and Critical Care Medicine, Department of Biochemistry and Molecular Biology, and.
概括
向谷氨胺转运体SLC1A5 (溶性载体转运体1A5) 抑制转化生长因子β (TGF-β) 诱导的纤维细胞激活. 这种代谢方法为纤维增殖性疾病提供了一种新的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 代谢途径 代谢途径
- 纤维化研究 纤维化研究
背景情况:
- 谷氨酸对于转化增长因子-β (TGF-β) 诱导的肌纤维细胞激活至关重要.
- 溶解物载体载体1A5 (SLC1A5) 是细胞谷氨胺吸收的主要载体.
- 异常的细胞代谢与纤维增殖性疾病有关.
研究的目的:
- 研究SLC1A5在TGF-β诱导的纤维细胞激活中的作用.
- 评估SLC1A5作为纤维增殖性疾病的治疗点.
- 探索纤维细胞中SLC1A5抑制的代谢后果.
主要方法:
- 在纤维化肺纤维细胞中分析SLC1A5表达.
- 评估TGF-β诱导的纤维细胞激活标志物 (益纤维细胞标,迁移,结独立生长).
- 使用小分子抑制剂V-9302.2抑制SLC1A5的抑制.
- 评估细胞代谢参数 (自,mTOR,HIF,Myc信号传递,线粒体功能,ATP产生,糖解).
- 在活体研究中,使用白胺诱导的肺纤维化小鼠模型.
主要成果:
- 在纤维化肺纤维细胞和异常性肺纤维化 (IPF) 纤维细胞中,SLC1A5的表达很高.
- TGF-β诱导的纤维细胞激活取决于SLC1A5的活性.
- 抑制SLC1A5抑制了关键的益纤维细胞通路,并损害了纤维细胞代谢功能.
- 使用V-9302对SLC1A5的药理抑制逆转了profibrotic转录形状,并在体内减弱了肺纤维化.
结论:
- 准SLC1A5取消了由TGF-β驱动的纤维细胞激活的多个方面.
- 通过向细胞代谢,SLC1A5抑制代表了针对纤维增殖性疾病的新疗法策略.
- 这项研究为通过调节谷氨胺运输来开发纤维化新疗法提供了框架.
更多相关视频
02:46A Mouse Model of Pulmonary Fibrosis Induced by Nasal Bleomycin Nebulization
Published on: January 20, 2023
3.7K
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
11.5K
相关概念视频
Glucose Transporters
23.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
23.2K
Cystic Fibrosis: Pathogenesis
293
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
293
